Epidemiology of inpatient gout in Australia and New Zealand: temporal trends, comorbidities and gout flare site-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epidemiology of inpatient gout in Australia and New Zealand: temporal trends, comorbidities and gout flare site

Published:2016-07-26 Issue:6 Volume:20 Page:779-784
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Robinson Philip C.¹²,Kempe Sarina³,Tebbutt Ian⁴,Roberts Lynden⁵⁶

Affiliation:

1. School of Medicine; Faculty of Medicine and Biomedical Sciences; University of Queensland; Brisbane Queensland Australia

2. Department of Rheumatology; Royal Brisbane and Women's Hospital; Brisbane Queensland Australia

3. Department of Rheumatology; Monash Medical Centre; Melbourne Victoria Australia

4. Health Roundtable Limited; Sydney New South Wales Australia

5. Department of Rheumatology; Monash University; Melbourne Victoria Australia

6. Department of Medicine; Monash University; Melbourne Victoria Australia

Funder

Health Roundtable Limited

AstraZeneca

Menarini

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1756-185X.12941/fullpdf

Reference20 articles.

1. Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities;Robinson;Maturitas,2014

2. An observational study of gout prevalence and quality of care in a national Australian general practice population;Robinson;J Rheumatol,2015

3. Systematic review of the prevalence of gout and hyperuricemia in Australia;Robinson;Intern Med J,2012

4. Global epidemiology of gout: prevalence, incidence and risk factors;Kuo;Nat Rev Rheumatol,2015

5. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study;Kuo;Ann Rheum Dis,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 Inhibitors, but Not GLP-1 Receptor Agonists, Reduce Incidence of Gout in People Living With Type 2 Diabetes Across the Therapeutic Spectrum;Clinical Therapeutics;2024-07

2. Environmental factors and risk of gout;Environmental Research;2022-09

3. A nationwide wastewater-based assessment of metformin consumption across Australia;Environment International;2022-07

4. Persistence with urate‐lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions;British Journal of Clinical Pharmacology;2022-06-21

5. Evolving Role of Dual-Energy CT in the Clinical Workup of Gout: A Retrospective Study;American Journal of Roentgenology;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3